We are live on ! Find out more
NEPH icon

Nephros
NEPH

16 hedge funds and large institutions have $6.63M invested in Nephros in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

45% more capital invested

Capital invested by funds: $4.57M → $6.63M (+$2.06M)

0.05% less ownership

Funds ownership: 40.85% → 40.8% (-0.05%)

11% less funds holding

Funds holding: 18 → 16 (-2)

20% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 5

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
16
Holders Change
-2
Holders Change %
-11.11%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
4
Reduced
5
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
+$97.7K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$26K
3
HighTower Advisors
HighTower Advisors
Illinois
+$1.48K
4
Wells Fargo
Wells Fargo
California
+$4

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$39.2K
2
Citadel Advisors
Citadel Advisors
Florida
-$16.7K
3
TRCT
Tower Research Capital (TRC)
New York
-$16K
4
Renaissance Technologies
Renaissance Technologies
New York
-$14K
5
EP
Elkhorn Partners
Nebraska
-$7.38K
Name Holding Trade Value Shares
Change 		Change in
Stake
WC
1
Wexford Capital
Florida
$5.67M – – –
BA
2
Bard Associates
Illinois
$299K -$1.99K -1,350 -0.7%
Vanguard Group
3
Vanguard Group
Pennsylvania
$255K +$26K +17,613 +12%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$120K +$97.7K +66,216 +595%
HighTower Advisors
5
HighTower Advisors
Illinois
$89K +$1.48K +1,000 +2%
EP
6
Elkhorn Partners
Nebraska
$70K -$7.38K -5,000 -10%
William Blair & Company
7
William Blair & Company
Illinois
$56.2K – – –
State Street
8
State Street
Massachusetts
$24.3K – – –
Morgan Stanley
9
Morgan Stanley
New York
$23.7K – – –
Renaissance Technologies
10
Renaissance Technologies
New York
$21K -$14K -9,495 -41%
BlackRock
11
BlackRock
New York
$6.4K – – –
TRCT
12
Tower Research Capital (TRC)
New York
$859 -$16K -10,856 -95%
Wells Fargo
13
Wells Fargo
California
$102 +$4 +3 +5%
UBS Group
14
UBS Group
Switzerland
$17 -$334 -226 -95%
Osaic Holdings
15
Osaic Holdings
Arizona
$8 – – –
Susquehanna International Group
16
Susquehanna International Group
Pennsylvania
– -$39.2K -35,990 Closed
Citadel Advisors
17
Citadel Advisors
Florida
– -$16.7K -15,295 Closed

NEPH Hedge Fund Activity: Q2 2023 in Review

16 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Nephros (NEPH) for Q2 2023, worth a combined $6.63M — up 45% from $4.57M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of NEPH and 0 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 4 added.

The largest buyer was Geode Capital Management, adding an estimated $97.7K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $39.2K sold.

  • 16 institutional investors held Nephros (NEPH) as of Q2 2023, down from 18 in Q1 2023.
  • Funds reported $6.63M of Nephros stock for Q2 2023, up 45% quarter-over-quarter.
  • 0 funds opened new Nephros positions in Q2 2023 and 2 closed out, a net change of -2 holders.
  • The largest Nephros buyer in Q2 2023 was Geode Capital Management, an estimated $97.7K added.
  • The largest Nephros seller in Q2 2023 was Susquehanna International Group, an estimated $39.2K sold.

Based on aggregated 13F filings for Q2 2023.